vimarsana.com
Home
Live Updates
Treating Advanced - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Treating advanced - Page 1 : vimarsana.com
Patritumab Deruxtecan (HER3-DXd) in Patients with EGFR Mutation-Positive Advanced NSCLC
Dr. Gadgeel reviews the HERTHENA-Lung01 trial results of the HER3 targeting antibody drug conjugate patritumab deruxtecan in EGFR-positive non-small cell lung cancer.
Antibody drug conjugates
Treating advanced
Positive advanced
Lung cancer
Non small cell lung cancer
Sacituzumab Govitecan + Pembrolizumab in First-Line Metastatic NSCLC
Dr. Shirish Gadgeel discusses recent EVOKE-2 trial results showing promising response rates with sacituzumab govitecan combined with pembrolizumab for metastatic non-small cell lung cancer.
Sacituzumab govitecan
Antibody drug conjugates
Treating advanced
First line metastatic
Lung cancer
Non small cell lung cancer
Dato-DXd for Treating Advanced NSCLC
Benjamin Levy, MD, reviews clinical data on Dato-DXd in patients with advanced NSCLC and their practical implications.
Benjamin levy
Antibody drug conjugates
Treating advanced
Lung cancer
Non small cell lung cancer
T-DXd in HER2 Mutated Advanced NSCLC
Benjamin Levy, MD, reviews clinical data on T-DXd in HER2 mutated advanced NSCLC and their practical implications.
Benjamin levy
Antibody drug conjugates
Treating advanced
Lung cancer
Non small cell lung cancer
Molecular Testing in Advanced NSCLC
Benjamin Levy, MD, discusses the role of molecular testing in patients with advanced NSCLC.
Benjamin levy
Antibody drug conjugates
Treating advanced
Lung cancer
Non small cell lung cancer
vimarsana © 2020. All Rights Reserved.